Justices Urged To Skip Eligibility Case For Blood Test Patents
Medical testing companies Natera Inc. and Eurofins Viracor LLC told the U.S. Supreme Court Wednesday not to review the invalidation of Stanford University and CareDx patents on a blood test for...To view the full article, register now.
Already a subscriber? Click here to view full article